• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,493.54 504.86
( 0.65%)
Global Indices
Nasdaq
48,584.63 99.90
(0.21%)
Dow Jones
7,060.44 16.49
(0.23%)
Hang Seng
58,837.37 -680.97
(-1.14%)
Nikkei 225
10,588.49 28.91
(0.27%)
Forex
USD-INR
93.31 0.07
(0.07%)
EUR-INR
110.03 0.14
(0.13%)
GBP-INR
126.56 0.24
(0.19%)
JPY-INR
0.59 0.00
(0.06%)

EQUITY - MARKET SCREENER

Oxygenta Pharmaceutical Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524636
INE102E01018
-9.9177201
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
209.44
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

comfort intech ltd
Hindustan Unilever board OKs Rs 2,000-cr capex for capacity expansion
Feb 19,2026
The proposed investment is in line with the company’s strategy of focusing on fewer, bigger bets and strengthening its presence in high-growth demand spaces, including premium skin care and hair care and personal care & home care liquids.

Priya Nair, CEO and managing director, HUL, said: 'This investment reflects our strategic focus on scaling our brands and creating categories of the future to meet evolving consumer needs. It also underscores our commitment to building a resilient, technology-enabled supply chain that delivers superior value to consumers.'

Hindustan Unilever is in the FMCG business comprising primarily of Home Care, Beauty & Personal Care and Foods & Refreshment segments. The Company has manufacturing facilities across the country and sells primarily in India.

The company's consolidated net profit zoomed 120.91% to Rs 6,603 crore on 5.74% jump in revenue from operations to Rs 16,235 crore in Q3 FY26 over Q3 FY25.

The counter fell 1.90% to end at Rs 2279.50 on the BSE.